Back to results

Impact Of Viagra On Sexual Satisfaction Of Men With Mild Erectile Dysfunction Who Are Sexually Dissatisfied

Primary Purpose

Impotence

Status

Completed

Phase

Phase 4

Locations

Canada

Study Type

Interventional

Intervention

Viagra (Sildenafil citrate)

About this trial

This is an interventional treatment trial for Impotence

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)MaleDoes not accept healthy volunteers

Inclusion Criteria: Men above age of majority Mild erectile dysfunction (IIEF-EF 22-25) and sexual dissatisfaction (IIEF-OS 7 or less) Exclusion Criteria: Use of more than 4 doses of any PDE5 inhibitor in the past 12 weeks and use of any PDE5 inhibitor in the past 4 weeks Subjects currently taking any other commercially available drug or non-drug treatment for ED

Outcomes

Primary Outcome Measures

Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) Index at the End of the DB Treatment (Week 8)

adjusted mean : Possible scores for the EDITS Index range from 0 (extremely low treatment satisfaction) to 100 (extremely high treatment satisfaction).

Secondary Outcome Measures

Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) Index

Possible scores for the EDITS Index range from 0 (extremely low treatment satisfaction) to 100 (extremely high treatment satisfaction).

Change From Baseline to End of Double-Blind Phase (Week 8) in Patient Reported Erectile Function Assessment (PREFA) Total Score

adjusted mean change; PREFA Total Score: 8 = worst; 32 = best.

Patient Reported Erectile Function Assessment (PREFA) Total Score

PREFA Total Score: 8 = worst, 32 = best.

Change From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Erectile Function

adjusted mean change - Possible total scores for IIEF-EF range from 1 (worst) to 30 (best).

Change From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Orgasmic Function

adjusted mean change - Possible total scores for IIEF-OF range from 0 (worst) to 10 (best).

Change From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Sexual Desire

adjusted mean change - Possible total scores for IIEF-SD range from 2 (worst) to 10 (best).

Change From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Intercourse Satisfaction

adjusted mean - Possible total scores for IIEF-IS range from 0 (worst) to 15 (best).

Change From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Overall Satisfaction

adjusted mean change - Possible total scores for IIEF-OS range from 2 (worst) to 10 (best).

International Index of Erectile Function (IIEF) Domain Scores- Erectile Function

Possible total scores for IIEF-EF range from 1 (worst) to 30 (best).

International Index of Erectile Function (IIEF) Domain Scores- Orgasmic Function

Possible total scores for IIEF-OF range from 0 (worst) to 10 (best).

International Index of Erectile Function (IIEF) Domain Scores- Sexual Desire

Possible total scores for IIEF-SD and IIEF-OS range from 2 (worst) to 10 (best).

International Index of Erectile Function (IIEF) Domain Scores- Intercourse Satisfaction

Possible total scores for IIEF-IS range from 0 (worst) to 15 (best).

International Index of Erectile Function (IIEF) Domain Scores- Overall Satisfaction

Possible total scores for IIEF-SD and IIEF-OS range from 2 (worst) to 10 (best).

Change From Baseline to End of DB Phase (Week 8) in Erectile Distress Scale (EDS) Total Score

adjusted mean change - Possible total scores for EDS range from 5 (all of the time) to 30 (none of the time). Higher scores indicate less impact of ED.

Erectile Distress Scale (EDS) Total Score

Possible total scores for EDS range from 5 (all of the time) to 30 (none of the time). Higher scores indicate less impact of ED.

Change From Baseline to End of DB Phase (Week 8) in Quality of Erection Questionnaire (QEQ) Total Score

adjusted mean change - QEQ raw total score (defined as the sum of scores from QEQ Questions 1 and 3 to 7 and ranged from 6 to 30) was transformed to QEQ total score on a scale of 0 (lowest) to 100 (highest).

Quality of Erection Questionnaire (QEQ) Total Score

QEQ raw total score (defined as the sum of scores from QEQ Questions 1 and 3 to 7 and ranged from 6 to 30) was transformed to QEQ total score on a scale of 0 (lowest) to 100 (highest).

Global Efficacy Question 1 (GEQ1) Response at End of the Double-Blind Phase (Week 8) and at End of the Open-Label Phase (Week 14)

GEQ 1: Compared to having no treatment at all for your erection problem, has the medication you have been taking over the past 4 weeks improved your erections?Responder was defined as answering "Yes". % of responders/non-responders was calculated based on subjects who attempted intercourse.

Global Efficacy Question 2 (GEQ2) Response at End of the Double-Blind Phase (Week 8) and at End of the Open-Label Phase (Week 14)

GEQ 2: Compared to having no treatment at all for your erection problem, has the medication you have been taking over the past 4 weeks improved your ability to have sexual intercourse? Responder was defined as answering "Yes". % of responders/non-responders was calculated based on subjects who attempted intercourse.

Global Efficacy Question 3 (GEQ3) Response at End of the Double-Blind Phase (Week 8) and at End of the Open-Label Phase (Week 14)

GEQ 3: When you took a dose of study drug and had sexual stimulation, how often did you get an erection that allowed you to engage in satisfactory sexual intercourse? Resp. was defined as answering almost always or always, most times, or sometimes, and non-resp was defined as answering a few times or almost never or never.

Percentage of Occasions of Successful Intercourse (Event Log)

Percentage of occasions at which subjects answered yes to the question, did your erection last long enough to have successful intercourse. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.

Percentage of Occasions of Ejaculation and/or Orgasm (Event Log)

Percentage of Occasions of Successful Intercourse (Event Log)

Percentage of Occasions of Ejaculation and/or Orgasm Event Log

Change From Baseline to Week 8 in Analog Scales- Firmness

mean change - scale of 0 (worst) to 10 (best).

Change From Baseline to Week 8 in Analog Scales- Maintenance

mean change - scale of 0 (worst) to 10 (best).

Change From Baseline to Week 8 in Analog Scales- Reliability

mean change - scale of 0 (worst) to 10 (best).

Change From Baseline to Week 8 in Analog Scales- General Sexual Performance

mean change - scale of 0 (worst) to 10 (best)

Analog Scales- Firmness

mean - scale of 0 (worst) to 10 (best)

Analog Scales- Maintenance

mean - scale of 0 (worst) to 10 (best)

Analog Scales- Reliability

mean - scale of 0 (worst) to 10 (best)

Analog Scales- General Sexual Performance

mean - scale of 0 (worst) to 10 (best)

Shift in Responder Rate From Week 8 to Week 14 for Global Efficacy Question (GEQ) 1

Shift in Responder Rate From Week 8 to Week 14 for GEQ2

Shift in Responder Rate From Week 8 to Week 14 for GEQ3

GEQ3: When you took a dose of study drug and had sexual stimulation, how often did you get an erection that allowed you to engage in satisfactory sexual intercourse? Responder = almost always or always, most times, or sometimes. Non-responder = a few times (much less than half the time) or almost never or never.

Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of First Erections Grade 0

Per-patient percentage of hardness of erections:Grade 0 = no erection at all. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.

Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of First Erections Grade 1

Per-patient percentage of hardness of erections: Grade 1 = increase in size but not hard. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.

Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of First Erections Grade 2

Per-patient percentage of hardness of erections: Grade 2 = hard but not hard enough for penetration. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.

Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of First Erections Grade 3

Per-patient percentage of hardness of erections: Grade 3 = hard enough for penetration but not completely hard. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.

Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of First Erections Grade 4

Per-patient percentage of hardness of erections: Grade 4 = completely hard. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.

Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of First Erections Grade 3 or 4

Per-patient percentage of hardness of erections: Grade 3 = hard enough for penetration but not completely hard, Grade 4 = completely hard. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.

Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of Second Erections Grade 0

Per-patient percentage of hardness of second erections: Grade 0 = no erection at all. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.

Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of Second Erections Grade 1

Per-patient percentage of hardness of second erections: Grade 1 = increase in size but not hard. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.

Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of Second Erections Grade 2

Per-patient percentage of hardness of second erections:Grade 2 = hard but not hard enough for penetration. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.

Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of Second Erections Grade 3

Per-patient percentage of hardness of second erections:Grade 3 = hard enough for penetration but not completely hard. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.

Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of Second Erections Grade 4

Per-patient percentage of hardness of second erections:Grade 4 = completely hard. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.

Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of Second Erections Grade 3 or 4

Per-patient percentage of hardness of second erections: Grade 3 = hard enough for penetration but not completely hard, Grade 4 = completely hard. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.

Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Frequency of Second Erections

Percentage of occasions at which second erection was achieved. Calculation for each subject for each event log endpoint: percentage = (number of occasions with an answer of 'Yes' within visit interval) / (number of occasions within visit interval) x 100.

Full Information

NCT ID

NCT00301262

First Posted

March 7, 2006

Last Updated

January 28, 2021

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Collaborators

Pfizer

1. Study Identification

Unique Protocol Identification Number

NCT00301262

Brief Title

Impact Of Viagra On Sexual Satisfaction Of Men With Mild Erectile Dysfunction Who Are Sexually Dissatisfied

Official Title

A Multi-Center, Parallel Group, Flexible Dose Trial With A Double-Blind, Randomized, Placebo-Controlled Phase Followed By An Open-Label Phase To Assess The Impact Of Viagra On The Sexual Satisfaction Of Men With Mild Erectile Dysfunction

Study Type

Interventional

2. Study Status

Record Verification Date

January 2021

Overall Recruitment Status

Completed

Study Start Date

November 2005 (undefined)

Primary Completion Date

September 2007 (Actual)

Study Completion Date

September 2007 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title

Sponsor

Name of the Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Collaborators

Pfizer

4. Oversight

5. Study Description

Brief Summary

Men's quality of life (QoL) is potentially affected by mild erectile dysfunction (ED) to the same extent as it is by moderate and severe ED. This study will provide controlled clinical data measuring efficacy, QoL parameters and satisfaction changes in men with mild ED treated with Viagra versus those treated with a placebo. With an open-label extension, this study will also provide all study subjects the opportunity to receive the active drug treatment for 6 weeks.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study

Impotence

7. Study Design

Primary Purpose

Treatment

Study Phase

Phase 4

Interventional Study Model

Parallel Assignment

Masking

Double

Allocation

Randomized

Enrollment

183 (Actual)

8. Arms, Groups, and Interventions

Intervention Type

Drug

Intervention Name(s)

Viagra (Sildenafil citrate)

Primary Outcome Measure Information:

Title

Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) Index at the End of the DB Treatment (Week 8)

Description

adjusted mean : Possible scores for the EDITS Index range from 0 (extremely low treatment satisfaction) to 100 (extremely high treatment satisfaction).

Time Frame

Week 8

Secondary Outcome Measure Information:

Title

Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) Index

Description

Possible scores for the EDITS Index range from 0 (extremely low treatment satisfaction) to 100 (extremely high treatment satisfaction).

Time Frame

Week 8, Week 14

Title

Change From Baseline to End of Double-Blind Phase (Week 8) in Patient Reported Erectile Function Assessment (PREFA) Total Score

Description

adjusted mean change; PREFA Total Score: 8 = worst; 32 = best.

Time Frame

Week 8

Title

Patient Reported Erectile Function Assessment (PREFA) Total Score

Description

PREFA Total Score: 8 = worst, 32 = best.

Time Frame

Week 8, Week 14

Title

Change From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Erectile Function

Description

adjusted mean change - Possible total scores for IIEF-EF range from 1 (worst) to 30 (best).

Time Frame

Week 8

Title

Change From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Orgasmic Function

Description

adjusted mean change - Possible total scores for IIEF-OF range from 0 (worst) to 10 (best).

Time Frame

Week 8

Title

Change From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Sexual Desire

Description

adjusted mean change - Possible total scores for IIEF-SD range from 2 (worst) to 10 (best).

Time Frame

Week 8

Title

Change From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Intercourse Satisfaction

Description

adjusted mean - Possible total scores for IIEF-IS range from 0 (worst) to 15 (best).

Time Frame

Week 8

Title

Change From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Overall Satisfaction

Description

adjusted mean change - Possible total scores for IIEF-OS range from 2 (worst) to 10 (best).

Time Frame

Week 8

Title

International Index of Erectile Function (IIEF) Domain Scores- Erectile Function

Description

Possible total scores for IIEF-EF range from 1 (worst) to 30 (best).

Time Frame

Week 8, Week 14

Title

International Index of Erectile Function (IIEF) Domain Scores- Orgasmic Function

Description

Possible total scores for IIEF-OF range from 0 (worst) to 10 (best).

Time Frame

Week 8, Week 14

Title

International Index of Erectile Function (IIEF) Domain Scores- Sexual Desire

Description

Possible total scores for IIEF-SD and IIEF-OS range from 2 (worst) to 10 (best).

Time Frame

Week 8, Week 14

Title

International Index of Erectile Function (IIEF) Domain Scores- Intercourse Satisfaction

Description

Possible total scores for IIEF-IS range from 0 (worst) to 15 (best).

Time Frame

Week 8, Week 14

Title

International Index of Erectile Function (IIEF) Domain Scores- Overall Satisfaction

Description

Possible total scores for IIEF-SD and IIEF-OS range from 2 (worst) to 10 (best).

Time Frame

Week 8, Week 14

Title

Change From Baseline to End of DB Phase (Week 8) in Erectile Distress Scale (EDS) Total Score

Description

adjusted mean change - Possible total scores for EDS range from 5 (all of the time) to 30 (none of the time). Higher scores indicate less impact of ED.

Time Frame

Week 8

Title

Erectile Distress Scale (EDS) Total Score

Description

Possible total scores for EDS range from 5 (all of the time) to 30 (none of the time). Higher scores indicate less impact of ED.

Time Frame

Week 8, Week 14

Title

Change From Baseline to End of DB Phase (Week 8) in Quality of Erection Questionnaire (QEQ) Total Score

Description

Time Frame

Week 8

Title

Quality of Erection Questionnaire (QEQ) Total Score

Description

QEQ raw total score (defined as the sum of scores from QEQ Questions 1 and 3 to 7 and ranged from 6 to 30) was transformed to QEQ total score on a scale of 0 (lowest) to 100 (highest).

Time Frame

Week 8, Week 14

Title

Global Efficacy Question 1 (GEQ1) Response at End of the Double-Blind Phase (Week 8) and at End of the Open-Label Phase (Week 14)

Description

Time Frame

Week 8, Week 14

Title

Global Efficacy Question 2 (GEQ2) Response at End of the Double-Blind Phase (Week 8) and at End of the Open-Label Phase (Week 14)

Description

Time Frame

Week 8, Week 14

Title

Global Efficacy Question 3 (GEQ3) Response at End of the Double-Blind Phase (Week 8) and at End of the Open-Label Phase (Week 14)

Description

Time Frame

Week 8, Week 14

Title

Percentage of Occasions of Successful Intercourse (Event Log)

Description

Time Frame

Baseline to Week 8

Title

Percentage of Occasions of Ejaculation and/or Orgasm (Event Log)

Description

Time Frame

Baseline to Week 8

Title

Percentage of Occasions of Successful Intercourse (Event Log)

Description

Time Frame

Week 8 to Week 14

Title

Percentage of Occasions of Ejaculation and/or Orgasm Event Log

Description

Time Frame

Week 8 to Week 14

Title

Change From Baseline to Week 8 in Analog Scales- Firmness

Description

mean change - scale of 0 (worst) to 10 (best).

Time Frame

baseline to Week 8

Title

Change From Baseline to Week 8 in Analog Scales- Maintenance

Description

mean change - scale of 0 (worst) to 10 (best).

Time Frame

baseline to Week 8

Title

Change From Baseline to Week 8 in Analog Scales- Reliability

Description

mean change - scale of 0 (worst) to 10 (best).

Time Frame

baseline to Week 8

Title

Change From Baseline to Week 8 in Analog Scales- General Sexual Performance

Description

mean change - scale of 0 (worst) to 10 (best)

Time Frame

baseline to week 8

Title

Analog Scales- Firmness

Description

mean - scale of 0 (worst) to 10 (best)

Time Frame

Week 8, Week 14

Title

Analog Scales- Maintenance

Description

mean - scale of 0 (worst) to 10 (best)

Time Frame

Week 8, Week 14

Title

Analog Scales- Reliability

Description

mean - scale of 0 (worst) to 10 (best)

Time Frame

Week 8, Week 14

Title

Analog Scales- General Sexual Performance

Description

mean - scale of 0 (worst) to 10 (best)

Time Frame

Week 8, Week 14

Title

Shift in Responder Rate From Week 8 to Week 14 for Global Efficacy Question (GEQ) 1

Description

Time Frame

Week 8 to Week 14

Title

Shift in Responder Rate From Week 8 to Week 14 for GEQ2

Description

Time Frame

Week 8 to Week 14

Title

Shift in Responder Rate From Week 8 to Week 14 for GEQ3

Description

Time Frame

Week 8 to Week 14

Title

Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of First Erections Grade 0

Description

Time Frame

Baseline to <Week 8 and Week 8 to <=Week 14

Title

Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of First Erections Grade 1

Description

Time Frame

Baseline to <= Week 14

Title

Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of First Erections Grade 2

Description

Time Frame

Baseline to <Week 8 and Week 8 to <=Week 14

Title

Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of First Erections Grade 3

Description

Time Frame

Baseline to <Week 8 and Week 8 to <=Week 14

Title

Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of First Erections Grade 4

Description

Time Frame

Baseline to <Week 8 and Week 8 to <=Week 14

Title

Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of First Erections Grade 3 or 4

Description

Time Frame

Baseline to <Week 8 and Week 8 to <=Week 14

Title

Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of Second Erections Grade 0

Description

Time Frame

Baseline to <Week 8 and Week 8 to <=Week 14

Title

Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of Second Erections Grade 1

Description

Time Frame

Baseline to <Week 8 and Week 8 to <=Week 14

Title

Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of Second Erections Grade 2

Description

Time Frame

Baseline to <Week 8 and Week 8 to <=Week 14

Title

Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of Second Erections Grade 3

Description

Time Frame

Baseline to <Week 8 and Week 8 to <=Week 14

Title

Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of Second Erections Grade 4

Description

Time Frame

Baseline to <Week 8 and Week 8 to <=Week 14

Title

Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Hardness of Second Erections Grade 3 or 4

Description

Time Frame

Baseline to <Week 8 and Week 8 to <=Week 14

Title

Baseline to <Week 8 and Week 8 to <=Week 14 in Event Log: Frequency of Second Erections

Description

Time Frame

Baseline to <Week 8 and Week 8 to <=Week 14

10. Eligibility

Sex

Male

Minimum Age & Unit of Time

18 Years

Accepts Healthy Volunteers

Eligibility Criteria

Overall Study Officials:

First Name & Middle Initial & Last Name & Degree

Pfizer CT.gov Call Center

Organizational Affiliation

Pfizer

Official's Role

Study Director

Facility Information:

Facility Name

Pfizer Investigational Site

City

Calgary

State/Province

Alberta

ZIP/Postal Code

T2L 1K8

Country

Canada

Facility Name

Pfizer Investigational Site

City

Calgary

State/Province

Alberta

ZIP/Postal Code

T2V 4R6

Country

Canada

Facility Name

Pfizer Investigational Site

City

Edmonton

State/Province

Alberta

ZIP/Postal Code

T5H 4B9

Country

Canada

Facility Name

Pfizer Investigational Site

City

Langley

State/Province

British Columbia

ZIP/Postal Code

V3A 4H9

Country

Canada

Facility Name

Pfizer Investigational Site

City

Surrey

State/Province

British Columbia

ZIP/Postal Code

V3V 1N1

Country

Canada

Facility Name

Pfizer Investigational Site

City

Vancouver

State/Province

British Columbia

ZIP/Postal Code

V5Z 1K3

Country

Canada

Facility Name

Pfizer Investigational Site

City

Vancouver

State/Province

British Columbia

ZIP/Postal Code

V6Z 2T1

Country

Canada

Facility Name

Pfizer Investigational Site

City

Victoria

State/Province

British Columbia

ZIP/Postal Code

V8T 5G1

Country

Canada

Facility Name

Pfizer Investigational Site

City

Bay Roberts

State/Province

Newfoundland and Labrador

ZIP/Postal Code

A0A 1G0

Country

Canada

Facility Name

Pfizer Investigational Site

City

Halifax

State/Province

Nova Scotia

ZIP/Postal Code

B3H 3A7

Country

Canada

Facility Name

Pfizer Investigational Site

City

Barrie

State/Province

Ontario

ZIP/Postal Code

L4M 7G1

Country

Canada

Facility Name

Pfizer Investigational Site

City

Corunna

State/Province

Ontario

ZIP/Postal Code

N0N 1G0

Country

Canada

Facility Name

Pfizer Investigational Site

City

Kingston

State/Province

Ontario

ZIP/Postal Code

K7L 3J7

Country

Canada

Facility Name

Pfizer Investigational Site

City

London

State/Province

Ontario

ZIP/Postal Code

N6A 4V2

Country

Canada

Facility Name

Pfizer Investigational Site

City

Oakville

State/Province

Ontario

ZIP/Postal Code

L6H 3P1

Country

Canada

Facility Name

Pfizer Investigational Site

City

Sarnia

State/Province

Ontario

ZIP/Postal Code

N7T 4X3

Country

Canada

Facility Name

Pfizer Investigational Site

City

Toronto

State/Province

Ontario

ZIP/Postal Code

M5T 2S8

Country

Canada

Facility Name

Pfizer Investigational Site

City

Toronto

State/Province

Ontario

ZIP/Postal Code

M6A 3B5

Country

Canada

Facility Name

Pfizer Investigational Site

City

Chicoutimi

State/Province

Quebec

ZIP/Postal Code

G7H 4A3

Country

Canada

Facility Name

Pfizer Investigational Site

City

L'Ancienne-Lorette

State/Province

Quebec

ZIP/Postal Code

G2E 2X1

Country

Canada

Facility Name

Pfizer Investigational Site

City

Montreal

State/Province

Quebec

ZIP/Postal Code

H2L 5B1

Country

Canada

Facility Name

Pfizer Investigational Site

City

Montreal

State/Province

Quebec

ZIP/Postal Code

H2X 1N8

Country

Canada

Facility Name

Pfizer Investigational Site

City

Montreal

State/Province

Quebec

ZIP/Postal Code

H3S 1Z1

Country

Canada

Facility Name

Pfizer Investigational Site

City

Montréal

State/Province

Quebec

ZIP/Postal Code

H2X 1N8

Country

Canada

Facility Name

Pfizer Investigational Site

City

Pointe-Claire

State/Province

Quebec

ZIP/Postal Code

H9R 4S3

Country

Canada

Facility Name

Pfizer Investigational Site

City

Sherbrooke

State/Province

Quebec

ZIP/Postal Code

J1H 1Z1

Country

Canada

Facility Name

Pfizer Investigational Site

City

St. Leonard

State/Province

Quebec

ZIP/Postal Code

H1S 3A9

Country

Canada

12. IPD Sharing Statement

Citations:

PubMed Identifier

28892218

Citation

Kaminetsky JC, Stecher V, Tseng LJ. Quality of erections by age group in men with erectile dysfunction. Int J Clin Pract. 2017 Oct;71(10). doi: 10.1111/ijcp.12976. Epub 2017 Sep 11.

Results Reference

derived

Links:

URL

https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A1481238&StudyName=Impact%20Of%20Viagra%20On%20Sexual%20Satisfaction%20Of%20Men%20With%20Mild%20Erectile%20Dysfunction%20Who%20Are%20Sexually%20Dissatisfied

Description

To obtain contact information for a study center near you, click here.

Learn more about this trial

Impact Of Viagra On Sexual Satisfaction Of Men With Mild Erectile Dysfunction Who Are Sexually Dissatisfied

We'll reach out to this number within 24 hrs

Impact Of Viagra On Sexual Satisfaction Of Men With Mild Erectile Dysfunction Who Are Sexually Dissatisfied

Impotence

About this trial

Eligibility Criteria

Sites / Locations

Outcomes

Primary Outcome Measures

Secondary Outcome Measures

Full Information

1. Study Identification

2. Study Status

3. Sponsor/Collaborators

4. Oversight

5. Study Description

6. Conditions and Keywords

7. Study Design

8. Arms, Groups, and Interventions

10. Eligibility

12. IPD Sharing Statement

Learn more about this trial